News

• InterVene, Inc. Wins TCT 2019 Shark Tank Innovation Competition
• New Research Aims to Reduce Risk of Contrast-Induced Kidney Injury in High Risk Patients
• Study Finds Sustained Health Status Benefit for TAVR over SAVR at One Year
• Transcatheter Mitral Valve Replacement Found to Be Cost-Effective in Patients with Heart Failure and Severe Secondary Mitral Regurgitation
• New Five-Year Data Shows Similar Outcomes for TAVR and SAVR in Patients with Severe Aortic Stenosis and Intermediate Surgical Risk
• Three-Year COAPT Data Demonstrates Continued Safety and Effectiveness in Patients with Heart Failure and Secondary Mitral Regurgitation
• New Data Show that Patients with Left Main Disease Treated with PCI or CABG Have Similar Composite Outcomes at Five Years
• New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis
• New Self-expanding TAVR Prosthesis Does Not Meet Non-Inferiority Compared to SAPIEN 3
• TCT 2019 Master Operator Award to Be Presented to Shigeru Saito, MD
• Shortened Three-month DAPT Duration After PCI Demonstrates Low Rate of Adverse Events in High-Bleeding Risk Patients
• Biodegradable Polymer Everolimus-eluting Stent with Shortened DAPT is Safe and Effective for PCI in Patients with Unprotected Left Main Coronary Artery Disease
• Durable Polymer Drug-Eluting Stent Noninferior to a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated with One-Month DAPT
• Ticagrelor Without Aspirin Three Months After Successful PCI and DAPT Reduces Major Bleeding Without Increasing the Risk of Adverse Events
• TCT 2019 Career Achievement Award to be Presented to Robert O. Bonow, MD, MS
• CRF Fellow Publishes Research Letter Examining Pulmonary Embolism Outcomes in JAMA
• Announcing the TCT 2019 Late-Breaking Trials and Science
• TCT 2019 Agenda Now Available
• CRF And VEITHsymposium Announce an Alliance Between Transcatheter Cardiovascular Therapeutics (TCT) and VEITHsymposium
• Late-Breaking Science Announced for TVT 2019